Dalia Zaafar

551 total citations
33 papers, 357 citations indexed

About

Dalia Zaafar is a scholar working on Molecular Biology, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Dalia Zaafar has authored 33 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Pharmacology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Dalia Zaafar's work include Cholinesterase and Neurodegenerative Diseases (4 papers), Diabetes Treatment and Management (4 papers) and Medicinal Plants and Neuroprotection (3 papers). Dalia Zaafar is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (4 papers), Diabetes Treatment and Management (4 papers) and Medicinal Plants and Neuroprotection (3 papers). Dalia Zaafar collaborates with scholars based in Egypt, Saudi Arabia and United States. Dalia Zaafar's co-authors include Heba M. A. Khalil, Yasmine H. Ahmed, Alaa F. Bakr, Mohamed Y. Mahmoud, Rabab Ahmed Rasheed, Yasmin Abo‐zeid, Sawsan A. Zaitone, Zakaria Y. Abd Elmageed, Hayder M. Al‐kuraishy and Mohammed Alrouji and has published in prestigious journals such as PLoS ONE, Scientific Reports and Life Sciences.

In The Last Decade

Dalia Zaafar

32 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dalia Zaafar Egypt	14	106	46	36	30	30	33	357
Arthur José Pontes Oliveira de Almeida Brazil	6	192 1.8×	28 0.6×	28 0.8×	24 0.8×	37 1.2×	9	465
Maha H. Sharawy Egypt	15	138 1.3×	21 0.5×	33 0.9×	31 1.0×	18 0.6×	27	463
Tays Amanda Felisberto Gonçalves Brazil	6	156 1.5×	26 0.6×	22 0.6×	23 0.8×	35 1.2×	7	386
Agata Sarniak Poland	13	143 1.3×	42 0.9×	28 0.8×	27 0.9×	56 1.9×	26	602
Ataman Gönel Türkiye	12	158 1.5×	76 1.7×	43 1.2×	20 0.7×	64 2.1×	58	452
Başar Sırmagül Türkiye	11	88 0.8×	58 1.3×	23 0.6×	18 0.6×	19 0.6×	37	426
Xiaopeng Shi China	10	197 1.9×	55 1.2×	44 1.2×	16 0.5×	14 0.5×	47	479
Sahar A. Khaleel Egypt	12	195 1.8×	29 0.6×	22 0.6×	23 0.8×	22 0.7×	17	476
Maha Victor Agha Qatar	7	206 1.9×	18 0.4×	31 0.9×	35 1.2×	36 1.2×	10	482
Supeenun Unchern Thailand	11	182 1.7×	37 0.8×	73 2.0×	23 0.8×	38 1.3×	21	584

Countries citing papers authored by Dalia Zaafar

Since Specialization

Citations

This map shows the geographic impact of Dalia Zaafar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalia Zaafar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalia Zaafar more than expected).

Fields of papers citing papers by Dalia Zaafar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalia Zaafar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalia Zaafar. The network helps show where Dalia Zaafar may publish in the future.

Co-authorship network of co-authors of Dalia Zaafar

This figure shows the co-authorship network connecting the top 25 collaborators of Dalia Zaafar. A scholar is included among the top collaborators of Dalia Zaafar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalia Zaafar. Dalia Zaafar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khalaf, Marwa M., et al.. (2025). Reno-protective impact of diosmin and perindopril in amikacin-induced nephrotoxicity rat model: modulation of SIRT1/p53/C-FOS, NF-κB-p65, and keap-1/Nrf2/HO-1 signaling pathways. Immunopharmacology and Immunotoxicology. 47(3). 287–304. 2 indexed citations

Abdelrahim, Mohamed E. A., et al.. (2025). The impact of DPP-4 inhibitors on cardiovascular disease treatment: a comprehensive review of current therapeutic strategies and future directions. Molecular Biology Reports. 52(1). 400–400. 1 indexed citations

Zaafar, Dalia, et al.. (2025). Therapeutic impact of vildagliptin vs. gliclazide on insulin resistance and advanced glycated end product levels in newly diagnosed Egyptian diabetics: a randomized controlled trial. European Journal of Clinical Pharmacology. 81(11). 1593–1608.

Abdel‐Wahab, Basel A., et al.. (2024). Unraveling the impact of semaglutide in a diabetic rat model of testicular dysfunction: Insights into spermatogenesis pathways and miRNA-148a-5p. Steroids. 213. 109537–109537. 2 indexed citations

Zaafar, Dalia, et al.. (2024). Preparation and characterization of Sorafenib nano-emulsion: impact on pharmacokinetics and toxicity; an in vitro and in vivo study. Drug Delivery and Translational Research. 14(11). 3089–3111. 18 indexed citations

Mohsen, Engy, et al.. (2024). Impact of thermal processing on phytochemical profile and cardiovascular protection of Beta vulgaris L. in hyperlipidemic rats. Scientific Reports. 14(1). 27539–27539. 3 indexed citations

Zaafar, Dalia, et al.. (2024). Piperazine ferulate impact on diabetes-induced testicular dysfunction: unveiling genetic insights, MAPK/ERK/JNK pathways, and TGF-β signaling. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(6). 6719–6737. 3 indexed citations

George, Riham F., et al.. (2024). Design, synthesis, and biological evaluation of some new 2-phenyl-3,6-pyridazinedione derivatives as PDE-5 inhibitors. Bioorganic Chemistry. 145. 107213–107213. 3 indexed citations

Zaafar, Dalia, et al.. (2024). Unleashing new MTDL AChE and BuChE inhibitors as potential anti-AD therapeutic agents: In vitro, in vivo and in silico studies. International Journal of Biological Macromolecules. 268(Pt 1). 131740–131740. 6 indexed citations

10.

Zaafar, Dalia, et al.. (2023). Protective role of hesperetin in sorafenib-induced hepato- and neurotoxicity in mice via modulating apoptotic pathways and mitochondrial reprogramming. Life Sciences. 336. 122295–122295. 11 indexed citations

11.

Ahmed, Yasmine H., et al.. (2023). Combined β-sitosterol and trimetazidine mitigate potassium dichromate-induced cardiotoxicity in rats through the interplay between NF-κB/AMPK/mTOR/TLR4 and HO-1/NADPH signaling pathways. Environmental Science and Pollution Research. 30(25). 67771–67787. 18 indexed citations

12.

Alrouji, Mohammed, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Dalia Zaafar, & Gaber El‐Saber Batiha. (2023). Orexin pathway in Parkinson’s disease: a review. Molecular Biology Reports. 50(7). 6107–6120. 22 indexed citations

13.

Abdel‐Wahab, Basel A., et al.. (2023). Dapagliflozin alleviates arsenic trioxide-induced hepatic injury in rats via modulating PI3K/AkT/mTOR, STAT3/SOCS3/p53/MDM2 signaling pathways and miRNA-21, miRNA-122 expression. International Immunopharmacology. 127. 111325–111325. 13 indexed citations

14.

Issa, Marwa Y., Dalia Zaafar, Heba M. A. Khalil, et al.. (2022). Impact of different processing methods on the phenolics and neuroprotective activity of Fragaria ananassa Duch. extracts in a d-galactose and aluminum chloride-induced rat model of aging. Food & Function. 13(14). 7794–7812. 14 indexed citations

15.

Mahmoud, Mohamed Y., et al.. (2022). Switching indication of PEGylated lipid nanocapsules-loaded with rolapitant and deferasirox against breast cancer: Enhanced in-vitro and in-vivo cytotoxicity. Life Sciences. 305. 120731–120731. 15 indexed citations

16.

Zaafar, Dalia, et al.. (2022). Adherence to Insulin Therapy Among Children with Type 1 Diabetes: Reliability and Validity of the Arabic Version of the 4-Item Morisky Medication Adherence Scale. Patient Preference and Adherence. Volume 16. 1415–1421. 16 indexed citations

17.

Zaafar, Dalia, et al.. (2022). Coping strategies among children and adolescents: validity and reliability of the Arabic version of the Kidcope scale. Heliyon. 8(1). e08706–e08706. 5 indexed citations

18.

El‐Shiekh, Riham A., Heba M. A. Khalil, Mohamed Y. Mahmoud, et al.. (2022). Salix subserrata Bark Extract-Loaded Chitosan Nanoparticles Attenuate Neurotoxicity Induced by Sodium Arsenate in Rats in Relation with HPLC–PDA-ESI–MS/MS Profile. AAPS PharmSciTech. 24(1). 15–15. 13 indexed citations

19.

Orabi, Mohamed A. A., Heba M. A. Khalil, Mohamed E. Abouelela, et al.. (2021). Carissa macrocarpa Leaves Polar Fraction Ameliorates Doxorubicin-Induced Neurotoxicity in Rats via Downregulating the Oxidative Stress and Inflammatory Markers. Pharmaceuticals. 14(12). 1305–1305. 10 indexed citations

20.

Elsayed, Mohamed, et al.. (2021). Serum plasminogen activator inhibitor-1 levels in patients with major depressive disorder vs. healthy controls: a systematic review and meta-analysis. Trends in Psychiatry and Psychotherapy. 45. e20230338–e20230338. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact